The pathogenesis of specific rare diseases such as Smith-Lemli-Opitz syndrome and mevalonate kinase deficiency may arise from enzymatic defects in components of the sterol biosynthetic pathway, resulting in a shortage of downstream products [18,19]. The gene discussed is MVK; the disease is Smith-Lemli-Opitz syndrome.